The field of oncology has undergone a transformative shift with the emergence of targeted therapies designed to improve treatment precision and patient outcomes. Antibody drug conjugates (ADCs) represent a groundbreaking innovation by combining the specificity of monoclonal antibodies with the potency of cytotoxic drugs.  Increasing Adoption of Precision Medicine ApproachesThe growing...